Human-Animal Hybrid Experimentation in the U.K. is Halted
Research in the United Kingdom with human-animal hybrid experimentation has ground to a halt due to lack of funding.
January 13, 2009
Research in the United Kingdom with human-animal hybrid experimentation has ground to a halt due to lack of funding.
Pluristem Therapeutics has announced filing of applications with both the U.S. and European regulatory agencies to initiate clinical trials in the treatment of critical limb ischemia with adult stem cells.
Researchers at Stanford University have identified and isolated a population of highly potent adult stem cells from adult human testes.
Advantages of fat stem cells include their high concentration of mesenchymal stem cells, which seem to be able to block autoimmune attack, which is the major problem in multiple sclerosis.
Advanced Cell Technology and CHA Biotech announce the formation of a new stem cell company through a joint venture agreement.
Once again, Drosophila melanogaster enlightens the field of human medical science, this time with its stem cells.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.